| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/15/2022 | 233.33% | Canaccord Genuity | $8 → $7 | Maintains | Buy |
| 05/13/2022 | 709.52% | Keybanc | $20 → $17 | Maintains | Overweight |
| 03/25/2022 | 852.38% | Keybanc | $30 → $20 | Maintains | Overweight |
| 11/11/2021 | 1328.57% | Keybanc | $33 → $30 | Maintains | Overweight |
| 04/15/2021 | 1090.48% | Canaccord Genuity | → $25 | Initiates Coverage On | → Buy |
| 03/02/2021 | 1471.43% | Keybanc | $32 → $33 | Maintains | Overweight |
| 11/10/2020 | 1423.81% | Keybanc | → $32 | Initiates Coverage On | → Overweight |
| 10/08/2020 | 757.14% | BTIG | → $18 | Initiates Coverage On | → Buy |
| 06/02/2020 | 852.38% | Cantor Fitzgerald | $19 → $20 | Assumes | → Overweight |
| 11/13/2019 | 1090.48% | Cantor Fitzgerald | $18 → $25 | Maintains | Overweight |
| 10/14/2019 | 757.14% | Cantor Fitzgerald | → $18 | Initiates Coverage On | → Overweight |
| 10/14/2019 | 709.52% | Cowen & Co. | → $17 | Initiates Coverage On | → Outperform |
| 10/14/2019 | — | William Blair | Initiates Coverage On | → Outperform |
What is the target price for Exagen (XGN)?
The latest price target for Exagen (NASDAQ: XGN) was reported by Canaccord Genuity on November 15, 2022. The analyst firm set a price target for $7.00 expecting XGN to rise to within 12 months (a possible 233.33% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Exagen (XGN)?
The latest analyst rating for Exagen (NASDAQ: XGN) was provided by Canaccord Genuity, and Exagen maintained their buy rating.
When is the next analyst rating going to be posted or updated for Exagen (XGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exagen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exagen was filed on November 15, 2022 so you should expect the next rating to be made available sometime around November 15, 2023.
Is the Analyst Rating Exagen (XGN) correct?
While ratings are subjective and will change, the latest Exagen (XGN) rating was a maintained with a price target of $8.00 to $7.00. The current price Exagen (XGN) is trading at is $2.10, which is out of the analyst's predicted range.